Soluble α -Klotho serum levels in chronic kidney disease

97Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transmembrane α-Klotho (TM-Klotho), expressed in renal tubules, is a cofactor for FGF23-receptor. Circulating soluble-α-Klotho (s-Klotho) results from TM-Klotho shedding and acts on Phosphate (P) and Calcium (Ca) tubular transport. Decreased TM-Klotho, described in experimental chronic kidney disease (CKD), prevents actions of FGF23 and lessens circulating s-Klotho. Thus, levels of s-Klotho could represent a marker of CKD-MBD. To evaluate the clinical significance of s-Klotho in CKD we assayed serum s-Klotho and serum FGF23 in 68 patients (age 58±15; eGFR 45±21 mL/min). s-Klotho was lower than normal (519±183 versus 845±330 pg/mL, P

Cite

CITATION STYLE

APA

Rotondi, S., Pasquali, M., Tartaglione, L., Muci, M. L., Mandanici, G., Leonangeli, C., … Mazzaferro, S. (2015). Soluble α -Klotho serum levels in chronic kidney disease. International Journal of Endocrinology, 2015. https://doi.org/10.1155/2015/872193

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free